G-DISCO
Bladder — Recruiting
G-DISCO
If you think this trial might be right for you, please ask your doctor.
If you think this trial might be right for you, please ask your doctor.
Trial Title
A Phase 1 study of feasibility, safety and tolerability of synchronous intravesical administration of gemcitabine and docetaxel
Cancer Type
Bladder
Trial Status
Recruiting
Protocol Number
ANZUP 2403
Trial Email
Study Chair
Dickon Hayne, Cynthia Hawks
Study Objective
Test feasibility, safety and tolerability of synchronous intravesical administration of gemcitabine and docetaxel.
Patient Population
Males and females aged 18 years and over who have fully resected high-risk non-muscle-invasive bladder cancer (HRNMIBC) that is unresponsive to intravesical therapy, an ECOG status of 0-2, a life expectancy of > 6 months, and adequate organ and bone marrow function.
Primary Outcome
Feasibility of synchronous administration of intravesical gemcitabine and docetaxel.
Recruitment Target
15 people
Detailed Information
Participating Centres
WA
Fiona Stanley Hospital